期刊文献+

2004~2006年我院神经系统药物应用分析 被引量:6

Use of Nervous System Drugs in Our Hospital from 2004 to 2006:Analysis of the Status Quo and Trend
下载PDF
导出
摘要 目的:了解我院神经系统药物的使用情况及其变化趋势,为临床合理应用提供参考。方法:采用用药金额排序法和限定日剂量法对我院2004~2006年神经系统药物的使用情况进行评估。结果:2004~2006年我院神经系统药物消耗金额分别占全院药品的14.21%、15.10%和16.84%。影响脑血管、脑代谢及促智的药物占首位,用药金额呈现下降趋势。镇痛药和抗癫痫药增长较快,2006年抗癫痫药已占神经系统药物金额的9。23%。用药频度居前的药品多为价格低廉、疗效肯定、适于口服的品种。结论:神经系统药物在临床治疗中发挥着越来越重要的作用。从用药金额角度来看,以影响脑血管、脑代谢及促智的药物为主;从用药频度来看,以价格低廉、疗效肯定、适于口服的品种为主。 OBJECTIVE: To investigate the utilization and developing trend of nervous system drugs in our hospital for reference of clinical rational drug use. METHODS : The utilization of nervous system drugs during the period 2004-2006 was evaluated using the order of consumption sum and defined daily dose (DDDs) . RESULTS: Of the total drugs used in our hospital during the period 2004-2006, the consumption of nervous system drugs account for 14.21%, 15.10% and 16.84 % respectively. Dominating the first places were drugs influencing cerebral vessels and cerebral metabolism, and nootropic drug, but their amount of money presented downtrend. The consumption of analgesics and antiepileptics increased rapidly, with antiepileptics accounting for 9,23 % of the total nervous system drugs in 2006. Topping the list of DDDs were predominantly those medicines that with low price and proved efficiency and are suitable for oral use. CONCLUSION: The use of nervous system drugs assumes an increasingly important role in clinical treatment. In terms of consumption sum of money, the drugs which influence cerebral vessels and cerebral metabolism, and nootropic drug took the lead; in terms of DDDs, those medicines that with low price and proved efficiency and are suitable for oral use took the lead.
出处 《中国医院用药评价与分析》 2008年第4期261-263,共3页 Evaluation and Analysis of Drug-use in Hospitals of China
关键词 神经系统药物 用药金额 限定日剂量 Nervous system drugs Drug consumption sum Defined daily dose
  • 相关文献

参考文献4

二级参考文献17

  • 1赵高峰,张兴安,施冲,吴群林,徐波.靶控输注异丙酚复合瑞芬太尼或芬太尼全静脉麻醉[J].广东医学,2004,25(7):765-767. 被引量:103
  • 2姚伟瑜,李师阳,肖全胜,吴建文,郑清民,房小斌,谢钱灵.瑞芬太尼在人工流产术中的应用[J].临床麻醉学杂志,2004,20(9):559-559. 被引量:7
  • 3王学斌,高军,曾玲双,李忠田.瑞芬太尼在全麻联合硬膜外麻醉行腹腔镜胆囊切除术29例[J].第四军医大学学报,2005,26(8):724-726. 被引量:4
  • 4[3]Westmoreland CL,Hoke JF,Sebel PS,et al.Pharmacokinetics of remifentail (GI87084 B)and its magor metabolite(GI90291)in pa tients underging elective inpatient surgery.Anesthesiology,1993,79(5):893-898
  • 5[4]David R,Harry JM.Population pharmacokinetics and pharmacody namics of remifentanil as a supplement to nitrous oxide anesthesi ology,1998,89:869-877
  • 6Ko S H,Kim D C,Han Y J,et al.Small dose fentanyl:optimal time of injection for blunting the circulatory responses to tracheal intubation[J].Anesth Analg,1998,86(3):658-661.
  • 7Pleym H,Stenseth R,Wiseth R,et al.Supplemental remifentanil during coronary artery bypass grafting is followed by a transient postoperative cardiac depression[J].Acta Anaesthesiol Scand,2004,48(9):1 155-1 162.
  • 8Sneyd JR,Camu F,Doenicke A,et al.Remifentanil and fentanyl during aneathesia for major abdomical and gynaecological surgery.An open,oparative study of safety and efficacy[J].Eur J Anaeth,2001,18(9):605-614.
  • 9Schuttler J,Albrecht S,Breivik H,et al.A comparison of remifentanil and alfentanil in patients undergoing major abdominal surgery[J].Anesthesia,1997,52(4):307-317.
  • 10Myre K,Raeder J,Rostrup M,et al.Catecholamine release during laparoscopic fundoplication with high and low doses of remifentanil[J].Acta Anaethesia Scand,2003,47(3):267-273.

共引文献50

同被引文献32

引证文献6

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部